The low-dose streptozocin (STZ) model of diabetes has been reported to involve direct STZ beta-cytotoxicity and/or immunologically mediated β-cell destruction. Because the T-lymphocyte dependency of such a model is controversial, we further assessed the role of T-lymphocytes by determining the occurrence and magnitude of hyperglycemia as well as the pancreatic insulin contents in both STZ-injected nude C57BL/6J male mice and STZ-injected euthymic C57BL/6J male mice selectively depleted in helper and/or cytotoxic T-lymphocytes with monoclonal antibodies (MoAbs). The effectiveness of MoAb treatment was assessed in lymph node cells by flow-microfluorometry analysis and in spleen cells by concanavalin A stimulation, allospecific cytotoxic T-lymphocyte activity, and T-lymphocyte lymphokine production. Sixteen days after the first STZ injection, hyperglycemia (plasma glucose > 200 mg/dl) occurred in significantly fewer helper T-lymphocyte-depleted mice (P < .005) or helper and cytotoxic T-lymphocyte–depleted mice (P < .001) than in non–MoAb-treated mice. However, a progressive increase in the number of mice with hyperglycemia ensued in all MoAb-treated groups, and 2 mo after STZ was administered, the prevalence of hyperglycemia, mean plasma glucose levels, and pancreatic insulin contents did not differ significantly from the values obtained in the non–MoAb-treated animals. Similarly, STZ-injected C57BL/6J male nude mice developed hyperglycemia that was associated with a marked decrease in pancreatic insulin contents on a time course comparable with that of STZ-injected euthymic C57BL/6J male mice depleted in helper or in helper and cytotoxic T-lymphocytes by MoAbs. Thus, selective helper T-lymphocyte depletion, either genetic or induced by MoAb treatment, although able to temporarily protect mice from the development of hyperglycemia, did not prevent the ultimate loss of the β-cell mass initiated by the direct toxic effect of STZ.
Skip Nav Destination
Article navigation
Original Articles|
August 01 1988
Effect of Helper and/or Cytotoxic T-Lymphocyte Depletion on Low-Dose Streptozocin-Induced Diabetes in C57BL/6J Mice
Marie-Dominique Dayer-Métroz;
Marie-Dominique Dayer-Métroz
Institute of Clinical Biochemistry, Department of Medicine and Department of Pathology, University of Geneva, Centre Médical Universitaire
Geneva, Switzerland
Search for other works by this author on:
Makoto Kimoto;
Makoto Kimoto
Institute of Clinical Biochemistry, Department of Medicine and Department of Pathology, University of Geneva, Centre Médical Universitaire
Geneva, Switzerland
Search for other works by this author on:
Shozo Izui;
Shozo Izui
Institute of Clinical Biochemistry, Department of Medicine and Department of Pathology, University of Geneva, Centre Médical Universitaire
Geneva, Switzerland
Search for other works by this author on:
Pierre Vassalli;
Pierre Vassalli
Institute of Clinical Biochemistry, Department of Medicine and Department of Pathology, University of Geneva, Centre Médical Universitaire
Geneva, Switzerland
Search for other works by this author on:
Albert E Renold
Albert E Renold
Institute of Clinical Biochemistry, Department of Medicine and Department of Pathology, University of Geneva, Centre Médical Universitaire
Geneva, Switzerland
Search for other works by this author on:
Address correspondence and reprint requests to M.-D. Dayer-Métroz, Institut de Biochimie Clinique, Centre Médical Universitaire, University of Geneva, 1211 Geneva 4, Switzerland.
1
Died on 21 March 1988
Diabetes 1988;37(8):1082–1089
Article history
Received:
October 19 1987
Revision Received:
February 03 1988
Accepted:
February 03 1988
PubMed:
3260567
Citation
Marie-Dominique Dayer-Métroz, Makoto Kimoto, Shozo Izui, Pierre Vassalli, Albert E Renold; Effect of Helper and/or Cytotoxic T-Lymphocyte Depletion on Low-Dose Streptozocin-Induced Diabetes in C57BL/6J Mice. Diabetes 1 August 1988; 37 (8): 1082–1089. https://doi.org/10.2337/diab.37.8.1082
Download citation file:
63
Views